NASDAQ:BMEA • US09077A1060
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BIOMEA FUSION INC (BMEA).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-28 | D. Boral Capital | Maintains | Buy -> Buy |
| 2026-04-08 | D. Boral Capital | Maintains | Buy -> Buy |
| 2026-03-27 | Citigroup | Maintains | Buy -> Buy |
| 2026-03-25 | D. Boral Capital | Maintains | Buy -> Buy |
| 2026-01-13 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-11-10 | Citigroup | Maintains | Buy -> Buy |
| 2025-11-05 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-10-27 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-10-07 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-10-03 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-28 | Jefferies | Initiate | Buy |
| 2025-08-11 | Citigroup | Maintains | Buy -> Buy |
| 2025-08-06 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-06 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-07-21 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-07-16 | Citigroup | Maintains | Buy -> Buy |
| 2025-06-24 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-06-18 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-06-13 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-05-15 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-05-06 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-05-06 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-04-02 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A -100.00% | N/A | N/A 104.46% | N/A 176.78% | N/A 104.40% | ||||||||
| EBITDA YoY % growth | -1.2M | -5.32M -343.33% | -41.42M -678.57% | -82.94M -100.24% | -124.62M -50.25% | -142.322M -14.20% | -79.898M 43.86% | N/A 10.86% | N/A -29.03% | N/A -14.37% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -1.2M | -5.33M -344.17% | -41.67M -681.80% | -83.63M -100.70% | -126.135M -50.83% | -144.07M -14.22% | -81.307M 43.56% | N/A -15.19% | N/A -21.11% | N/A -16.90% | N/A -7.12% | N/A 62.22% | N/A 161.67% | N/A 1,032.94% | N/A 162.18% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | -1.76 | -2.79 -58.52% | -3.46 -24.01% | -3.84 -10.98% | -1.31 65.89% | N/A 28.60% | N/A -32.97% | N/A 26.28% | N/A -13.48% | N/A 92.16% | N/A 2,025.00% | N/A 210.39% | N/A 108.79% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.24 69.61% | -0.24 53.67% | -0.24 11.85% | -0.24 -187.52% | -0.24 -0.70% | -0.26 -7.91% | -0.27 -11.43% | -0.28 -16.55% |
| Revenue Q2Q % growth | ||||||||
| EBITDA Q2Q % growth | -12.622M 56.84% | -15.084M 25.84% | -18.004M -4.44% | -25.514M -147.46% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -18.98M 36.12% | -18.629M 12.44% | -19.885M -6.91% | -23.741M -102.59% | -17.85M 5.95% | -18.87M -1.29% | -19.38M 2.54% | -20.4M 14.07% |
All data in USD
13 analysts have analysed BMEA and the average price target is 7.31 USD. This implies a price increase of 404.14% is expected in the next year compared to the current price of 1.45.
BIOMEA FUSION INC (BMEA) will report earnings on 2026-05-06.
The consensus EPS estimate for the next earnings of BIOMEA FUSION INC (BMEA) is -0.24 USD and the consensus revenue estimate is 0 USD.